Literature DB >> 27994725

Imidazopyridazine Inhibitors of PI3Kβ.

Gerard Rosse1.   

Abstract

Entities:  

Year:  2016        PMID： 27994725      PMCID： PMC5150669          DOI： 10.1021/acsmedchemlett.6b00406

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy.

Authors:  Arindam Ghosh Mazumder; Yogendra Shantaram Padwad; Damanpreet Singh
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388

Review 2.  Class II Phosphoinositide 3-Kinases as Novel Drug Targets.

Authors:  Marco Falasca; Justin R Hamilton; Maria Selvadurai; Krithika Sundaram; Aleksandra Adamska; Philip E Thompson
Journal:  J Med Chem       Date:  2016-10-21       Impact factor: 7.446
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.